GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
- DOI
- 10.1186/s13045-016-0235-8
- Published
- 2016 Jan 27
- Container
- Journal of hematology & oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-016-0235-8,
title = {GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.},
author = {Guerenne L and Beurlet S and Said M and Gorombei P and Le Pogam C and Guidez F and de la Grange P and Omidvar N and Vanneaux V and Mills K and Mufti GJ and Sarda-Mantel L and Noguera ME and Pla M and Fenaux P and Padua RA and Chomienne C and Krief P},
year = {2016},
journal = {Journal of hematology \& oncology},
doi = {10.1186/s13045-016-0235-8},
url = {https://doi.org/10.1186/s13045-016-0235-8}
}RIS
TY - JOUR TI - GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. AU - Guerenne L AU - Beurlet S AU - Said M AU - Gorombei P AU - Le Pogam C AU - Guidez F AU - de la Grange P AU - Omidvar N AU - Vanneaux V AU - Mills K AU - Mufti GJ AU - Sarda-Mantel L AU - Noguera ME AU - Pla M AU - Fenaux P AU - Padua RA AU - Chomienne C AU - Krief P PY - 2016 JO - Journal of hematology & oncology DO - 10.1186/s13045-016-0235-8 UR - https://doi.org/10.1186/s13045-016-0235-8 ER -
APA
L, G., S, B., M, S., P, G., C, L. P., F, G., P, D. L. G., N, O., V, V., K, M., GJ, M., L, S., ME, N., M, P., P, F., RA, P., C, C., & P, K. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-016-0235-8
Source records
- pubmed · retrieved 2026-09-27T14:03:16.620Z